BDNF and Alzheimer disease: ,42 Fluorescent staining revealed decreased MAP-2 intensity in the CA1 region of AD transgenic mice compared with WT littermates, which was restored following BDNF treatment (Fig. 3F, G), indicating enhanced neuronal structure.